Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
PaperCitations, authors & open-access status
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 312 citations, 2023 year and closed oa status.
312
Citations
2023
Year
closed
OA Status